Victoza (liraglutide): Complete Guide 2026
Victoza (liraglutide) is a once-daily injectable GLP-1 receptor agonist approved for the treatment of type 2 diabetes. As one of the earliest widely-used GLP-1 medications, Victoza established the class's reputation for effective blood sugar control with the added benefit of weight loss. The LEADER cardiovascular outcomes trial demonstrated that Victoza also reduces the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Enzo's Tip
Victoza is the OG of the GLP-1 family — it's been helping people manage diabetes since 2010! Think of it like Enzo the wise senior cat who's been around the block. Steady, reliable, and proven. Take it at the same time every day and you'll be purring along in no time! 🐱
Track your Victoza journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Quick Facts
| Generic Name | liraglutide |
| Manufacturer | Novo Nordisk |
| Type | Injectable pen |
| Frequency | Once weekly |
| Primary Indication | Type 2 diabetes |
Victoza Guides
Enzo reminds you when your next Victoza dose is due
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
The guide your doctor doesn't have time to give you
Your complete Victoza playbook: week-by-week guide, what to eat when nothing sounds good, and how to manage every side effect. Free.
No spam. Unsubscribe anytime.
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.